CVE-2025-61940 Details
Description
NMIS/BioDose V22.02 and previous versions rely on a common SQL Server user account to access data in the database. User access in the client application is restricted by a password authentication check in the client software but the underlying database connection always has access. The latest version of NMIS/BioDose introduces an option to use Windows user authentication with the database, which would restrict this database connection.
Multiple vulnerabilities have been identified in Mirion Medical's NMIS/BioDose software, specifically in versions through 22.02. These vulnerabilities stem from incorrect permission assignments that allow unauthorized access to critical resources, reliance on client-side authentication, and the use of hard-coded credentials. The incorrect permission assignments can enable users on client workstations to modify program executables and libraries, as well as access sensitive information from the SQL Server database and configuration files. The authentication vulnerability arises because the software uses a common SQL Server user account for database access, creating a persistent access point that could be exploited. Additionally, the presence of hard-coded passwords in the application's executable binaries further compounds these security issues, potentially allowing unauthorized access to both the application and its database.
Users are advised to update to version 23.0 or later. Those with an active support contract can contact Mirion Medical support for assistance.
Metrics
CVSS 4.0 Severity and Vector Strings:
CVSS 3.x Severity and Vector Strings:
No data available for CVSS Version 2.0 on this CVE.
CISA-ADP
Assessed Dec 9, 2025References to Advisories, Solutions, and Tools
By selecting these links, you will be leaving this site. These are references gathered from the official CVE record and are not endorsed by Volerion.
| URL | Source(s) | Tag(s) |
|---|---|---|
| https://www.cisa.gov/news-events/ics-medical-advisories/icsma-25-336-01 | [email protected] | Third Party Advisory |
Weakness Enumeration
| CWE-ID | CWE Name | Source |
|---|---|---|
| CWE-603 | Use of Client-Side Authentication | [email protected] |
Affected Products
| Product | Versions |
|---|---|
| mirion biodose/nmis | < 23.0 |
CPE
Remediation
| |
Change History
5 change records found show changes
| Date | Action | Recorded By |
|---|---|---|
| Sep 25, 2026 | CVE Translated | [email protected] |
| Jun 17, 2026 | CVE Modified | [email protected] |
| Jun 17, 2026 | CVE Modified | CISA-ADP |
| Jan 2, 2026 | Initial Analysis | [email protected] |
| Dec 2, 2025 | New CVE Received | [email protected] |